Phytochemical, Antioxidant, and Cytotoxicity screenings of n-hexane extract from Blumea balsamifera L leaves
Siti Rawati1, Binawati Ginting2*, Ilham Maulana2, Mustanir Yahya2, Nurdin Saidi2,
Murniana2, Kartini Hasballah3
1Postgraduate Student, Magister of Chemistry, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia.
2Department of Chemistry, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia.
3Department of Pharmacology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia.
*Corresponding Author E-mail: binawati@usk.ac.id
ABSTRACT:
The significance of phytomedicine in the field of medicine has encouraged researchers to investigate the potential medicinal properties of plants. Of which, phytoconstituents of Blumea balsamifera have been reported to possess multiple pharmacological benefits. Unfortunately, recent published reports only cover the essential oils of B. balsamifera, obtained from hydro-distillation. Hence, our research aimed to explore the bioactivities of B. balsamifera leaves extracted with n-hexane solvent through partitioning. Firstly, simplicial powder of B. balsamifera leaves was macerated using methanol, and followed by partitioning in a separating funnel with n-hexane solvent. The sample was assayed with 2,2-diphenyl-1-picrylhydrazyl (DPPH) and brine shrimp (Artemia salina) lethality test for antioxidant activity and cytotoxicity, respectively. Lastly, the phytochemical profile of the n-hexane extract was analyzed using gas chromatography – mass spectrometry (GC-MS). In the results, we found the n-hexane extract as a weak antioxidant (IC50=281.707ppm) and moderately cytotoxic agent (LC50=44.47ppm). GC chromatogram revealed the dominance of two phytoconstituents – borneol L (33.77%) and veridiflorol (22.57%), where both are known to have anticancer activities. In conclusion, bioactive and phytochemical screenings of n-hexane extract from Blumea balsamifera leaves suggested its anticancer potential. Future research involving purification of the phytocompound and investigation using cancer cell lines is encouraged.
KEYWORDS: Blumea balsamifera, borneol, BSLT, GC-MS, veridiflorol.
INTRODUCTION:
Amidst the advancement of technology in medicine, the role of traditional phytomedicine could still maintain its importance, even becoming an inspiration for modern drug discoveries1-5. In this light, our research group investigated several plants with potential medicinal properties, including Annona squamosa6,7 and Myristica fragrans8,9. Waste product from cacao (Theobroma cacao L) was found potential in performing antiproliferative activities, especially that of extracted using n-hexane10-12.
Previously, we have extracted Blumea balsamifera leaves using ethyl acetate solvent, where antioxidant activity of the extract could be used to biosynthesize Cu nanoparticles13,14. Taken altogether, B. balsamifera is one of the significant phytomedicine, in which its bioactivities required to be explored.
Herein, we intended to screen the bioactivity of B. balsamifera leaves extracted using n-hexane based on its antioxidant and cytotoxic activities. Most of previously reported investigations isolated the essential oils from B. balsamifera15. Antioxidant activity of B. balsamifera essential oils was found to inhibit nitric oxide (NO) radicals providing protective behavior on neural system against inflammation16. Anti-inflammatory behavior of essential oils from this plant was also observed in macrophage through the downregulation of proinflammatory cytokines namely tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-617. Nonetheless, literatures reporting on B. balsamifera leaves extracted using n-hexane solvent by means of partitioning is hardly to be found. Meanwhile, different extraction methods could yield bioactivities and chemical compounds18-21. Hence, this present work is important in filling the gap of research on providing the phytochemical profile of n-hexane extract from B. balsamifera leaves along with its antioxidant and cytotoxic activities.
MATERIALS AND METHODS:
In this study, the followings materials were used: methanol, n-hexane, 2,2-diphenyl-1-picrylhydrazyl (DPPH), and dimethyl sulfoxide. Vitamin C was purchased from the local pharmacy with pharmaceutical grade. Otherwise mentioned, all materials were procured from Merck (Selangor, Malaysia) and analytical grade. Plant specimen was collected from Aceh Selatan Regency, Aceh Province, Indonesia in October 2020. The specimen was brought to the Herbarium Laboratory in the Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Indonesia. The specimen was then identified as B. balsamifera L. Before used, the plant leaves were air-dried and crushed into fine powder.
n-Hexane extract from B. balsamifera L leaves was produced from the partition following the methanolic maceration of the plant simplicia (at room temperature; with four repetitions – 24 h each). The partition itself was performed using separating funnel with n-hexane solvent. The mixture was shaken rigorously, until two separated layer was formed (Figure 1a,b). The lipid layer formed at the bottom of the separating funnel was removed (Figure 1b). The remaining extract was evaporated using rotary evaporator (270 mbar; 50°C; 120rpm).
(A) (b)
Figure 1. Mixture of methanolic maceration product and n-hexane after a rigorous shaking (a) and the two separated layer with lipid residue formed after a few minutes (b).
Gas chromatography-mass spectroscopy (GC-MS) analysis was carried out to determine the phytoconstituents of the n-hexane extract from B. balsamifera. The GC-MS system utilized was that from Shimadzu, Kyoto, Japan with series no. QP2000A. Firstly, the sample (1μL) was injected into the the GC-MS column (Agilent 19091S-433 HP-5MS; 5% phenyl methyl siloxane). The analysis was performed with increasing temperature of 15°C/min and the flow rate was maintained at 1mL/min. Mass spectrometer acted as a detector for the eluted components of the n-hexane sample, where the data was compared with the reference from the National Institute of Standards and Technology (NIST).
Antioxidant properties of the extract was evaluated based on its scavenging activity against DPPH assay following the procedure from previous reports. The n-hexane extract was varied in concentration from 25, 50, to 100ppm, where the extract was dissolved with methanol until the total volume reached 5mL. DPPH 0.4 mM (1mL) was then added to the extract solution and the covered with aluminum foil. Thereafter, the mixture was vortexed until homogenous and incubated (37°C; 30 min). The concentration of DPPH was then measured using UV-vis spectrophotometer (UVmini-1240, Kyoto, Japan) at maximum wavelength of 517nm. Positive control used for the antioxidant properties was vitamin C or ascorbic acid (3—9ppm). The procedure was performed in duplicate.
Cytotoxicity of the n-hexane extract was screened using brine shrimp lethality test (BSLT) assay carried out in duplicate. Artemia salina larvae which had been previously hatched and grew for 48 h were placed onto 5 mL containing filled with sea water. The larvae were exposed to the respective n-hexane extract that had been varied in concentrations (1, 10, 100, 500, and 1000ppm) following the dilution with dimethyl sulfoxide. Each group consisted of 10 A. salina larvae. A group which was not exposed with the n-hexane extract was assigned as the control. The container was then stored under a tubular lamp and observed for 24 h.
Results from DPPH and BSLT assays were presented in averaged values. The minimum concentration required to inhibit a half of the DPPH concentration (IC50) and the minimum concentration required to yield 50% lethality (LC50) were obtained from a linear calibration curve. All data analyses were performed on OriginLab Software (Northampton, MA, USA).
RESULTS AND DISCUSSION:
Antioxidant activity of the n-hexane extract obtained from B. balsamifera L. leaves was determined based on DPPH inhibition assay, where the data have been presented in Figure 2. The increase on DPPH scavenging activity was found to be concentration-dependent. At highest concentration of the extract sample (100ppm), the inhibition of DPPH was 15.716%. Using the linear fitting curve, IC50 of the n-hexane extract sample was found reaching 281.707ppm. In comparison with the control, vitamin C (IC50=4.326 ppm), the IC50 value of the n-hexane extract was dramatically poorer. Antioxidant value obtained herein could be categorized as weak since the IC50 exceeded 250ppm22-24.
Figure 2. DPPH inhibition by n-hexane extract from B. balsamifera L. leaves
Low antioxidant activity does not mean that the extract has no active compounds, but it could be ascribed to the presence of inactive or inert compounds unreactive against DPPH. In a study employing Cu nanoparticles synthesized with Polyalthia longifolia roots, the DPPH scavenging activity of the sample was only 509.03ppm but could perform effective antimicrobial activities25. In our previous experiments, we also obtained relatively lower antioxidant activities in n-hexane extract, for example that of from Annona squamosa leaves6 and Myristica fragrans Houtt. barks9. Ethyl acetate extract from B. balsamifera L. leaves, on the other hand, was found to have IC50 of 64ppm for DPPH inhibition activity13. Essential oils extracted using diethyl ether had better DPPH assay-based antioxidant properties with the IC50s ranged from 24 to 29ppm15.
Cytotoxicities of the extract and fractions from B. balsamifera L leaves were screened by means of BSLT assay, in which the data have been presented (Figure 3). The number of died A. salina larvae increased as the concentration increased. As in control group, there was no mortality observed. At 100ppm of extract concentration, the mortality percentage was 40%. From the linear equation, the LC50 was found to be 44.47ppm. When the LC50 value falls within the range of 30—100 ppm, the phytocompounds could be categorized as moderately active as anticancer26. Hence, the n-hexane extract from B. balsamifera L. leaves was revealed as moderately active anticancer agent.
Figure 3. Mortality of A. salina with respect of n-hexane extract from B. balsamifera L. leaves in different concentrations.
Most of the plant n-hexane extracts are reported to possess high cytotoxicity, such as those from Theobroma cacao L. (0.29—2.37ppm)10,12. In another study, n-hexane extract from Abelmoschus manihot also possesses cytotoxic activity against breast cancer 4t1 cells line27. However, in a study comparing three extracts from Phyllanthus emblica stem barks obtained using n-hexane, ethyl acetate, and methanol, the n-hexane extract was found to have the lowest cytotoxic activity28. The B. balsamifera L leaves extract is potential to have improved LC50 when used with Cu nanoparticles13. Efficacy of B. balsamifera plant have been studied against hepatocellular carcinoma cells29 and cervical cancer cells30. Phytocompounds could facilitate the apoptosis of cells by targeting cancer-related biomolecules, such as glucosaminyl (N‑Acetyl) transferase 3, tyrosine‑protein kinase Met (c‑Met), peroxisome proliferator‑activated receptor γ, sex‑determining region Y and nuclear factor kappa beta 31-33. In the case B. balsamifera, the mechanism has been proven via APRIL – a member of tumor necrosis factor (TNF)34.
Chromatogram of the GC-MS analysis performed on n-hexane extract from B. balsamifera L leaves has been presented (Figure 4). The names of compounds along with their retention time and peak area (%) have been presented in Table 1. Two compounds appear to dominate the phytoconstituents of the extract sample, namely borneol L (33.77%) and veridiflorol (22.57%). Other phytocompounds had peak areas of less than 5%, they are: (-)-Caryophyllene oxide (4.95%); bicyclo[2.2.1]heptan-2-one,1,7,7-trimeth (4.01%); trans-caryophyllene (3.44%), beta-selinene (3.41%), and caryophyllene <14-hydroxy-9- (3.12%). In a previous study, the predominant phytocompounds of ethyl acetate extract from B. balsamifera L leaves included naphthalene, cryptomeridiol, eugenol13. Further isolation of the ethyl acetate extract, in different previous study, allowed the identification of lutein, beta-carotene, icthyothereol acetate, as well as cryptomeridiol35. Taken altogether, most of the phytocompounds identified herein, are newly reported for B. balsamifera leaves.
Both borneol L and veridiflorol are essential oils which are included as fragrance materials. Borneol has been reported in multiple times for its medicinal benefits including as ischemic stroke therapeutic agent 36 and vasorelaxant agent37. In the case of anticancer properties, borneol could induce cell apoptosis via reactive oxygen species (ROS)38,39. As for veridiflorol, the compound was found predominantly in Salvia macilenta Boiss. essential oil which had antimicrobial activities40. Similarly, methanolic extracts from Syzygium gratum and Melaleuca armillaris which both contained predominant veridiflorol, were reported to possess antimicrobial and antioxidant41. A plant-derived extract was found cytotoxic against human breast cancer cell line (MCF-7) and colon cancer cell line (HCT116) 42. Therefore, phytochemical profile of the n-hexane extract from B. balsamifera L leaves corroborates its potential as anticancer agent.
Figure 4. GC-MS chromatogram of n-hexane extract from B. balsamifera L leaves. Red arrows indicate the chromatogram belongs to borneol L (left) and veridiflorol (right).
Table 1. List of compounds identified from the GC-MS system from the B. balsamifera L leaves n-hexane extract.
|
Compounds |
Retention time (min) |
Area (%) |
|
Bicyclo[2.2.1]heptan-2-one,1,7,7-trimeth |
11.2271 |
4.01 |
|
Borneol L |
11.650 |
33.77 |
|
beta-Guaiene |
14.234 |
0.97 |
|
trans-Caryophyllene |
15.271 |
3.44 |
|
Alloaromadendrene |
15.802 |
2.40 |
|
Cycloheptan, 4-metylen-1-me |
17.197 |
0.92 |
|
(-)-Caryophyllene oxide |
17.341 |
4.95 |
|
Elemol |
17.690 |
0.48 |
|
Eudesmol <gamma-> db5-1951 |
17.875 |
0.52 |
|
Caryophyllene <14-hydroxy-9- |
17.966 |
3.12 |
|
beta-Selinene |
18.210 |
3.41 |
|
Androstan-17-one, 3-ethyl-3-hydroxy-, |
18.311 |
0.98 |
|
Ledene |
18.457 |
1.30 |
|
Veridiflorol |
19.977 |
22.57 |
|
9-Octadecenoic acid, 12-(acetyloxy)-, met |
20.857 |
1.97 |
|
Azuleno[4,5-b]furan-2(3H)-one, decarhydr |
22.425 |
0.91 |
|
9,12-Octadecadienoic acid (Z,Z)-, methyl |
22.506 |
0.79 |
|
9,12,15-Octadecatrien-1-ol (CAS) OCTA |
22.566 |
1.10 |
|
2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, |
22.668 |
2.94 |
|
Tetradecanoic acid, methyl ester (CAS) M |
22.791 |
0.62 |
|
S:d15-16-estrone-3-methylethe |
23.720 |
0.66 |
|
Isolongifolene |
23.819 |
0.82 |
|
Verrucarol |
24.049 |
1.06 |
|
5H-Cyclopropa[3,4]benz[1,2-e]azulen-5-o |
25.322 |
0.73 |
|
Ergost-25-ene-3,5,6,12-tetrol, (3.beta.,5.al) |
25.453 |
1.44 |
|
2,9-Heptadecadiene-4,6-diyn-8-ol, (Z,E)- |
25.863 |
1.89 |
CONCLUSION:
n-Hexane extract from B. balsamifera L leaves from by means of partitioning has weak antioxidant activity against DPPH radicals and moderate cytotoxicity based on BSLT assay. The presence of borneol L and veridiflorol as major phytoconstituents of the extract further suggest its potential as anticancer agent. Further studies need carried out to confirm the anticancer potential using cancer cell lines. Moreover, the isolation and identification of the pure compound are recommended to unearth the compound responsible for the anticancer drug.
CONFLICT OF INTEREST:
The authors have no conflicts of interest regarding this investigation.
ACKNOWLEDGMENTS:
Authors wish to appreciate the research funding given by Lembaga Penelitian Universitas Syiah Kuala through Lektor Kepala Scheme.
REFERENCES:
1. Li, X.; Chen, W.; Simal-Gandara, J.; Georgiev, M. I.; Li, H.; Hu, H.; Wu, X.; Efferth, T.; Wang, S., West meets east: open up a dialogue on phytomedicine. Chin Med 2021, 16 (1), 57.
2. Sharma, B.; Bagchi, A.; Bhutia, S.; Sarkar, B. R.; Pal, P., Formulation and evaluation of expectorant activity of poly herbal cough syrup from traditional medicinal plant extracts of North East India. Research Journal of Pharmacy and Technology 2022, 15 (3), 949-3.
3. Singh, V.; Sara, U. S.; Rizvi, A., Pharmacognostic evaluation and establishment of quality parameters of leaves of Prosopis cineraria. Research Journal of Pharmacy and Technology 2022, 15 (2), 621-7.
4. Bajes, H. R.; Oran, S. A.; Al-Dujaili, E. A. S., Investigating the anti-viral and anti-bacterial activities of Jordanian medicinal plants: A narrative review. Research Journal of Pharmacy and Technology 2022, 15 (2), 127-136.
5. Andalia, N.; Salim, M. N.; Saidi, N.; Ridhwan, M.; Iqhrammullah, M.; Balqis, U., Molecular Docking Reveals Phytoconstituents of the Methanol Extract from Muntingia calabura as Promising α-Glucosidase Inhibitors Muntingia calabura as Promising-Glucosidase Inhibitors. Karbala International Journal of Modern Science 2022, 8 (3), 330-338.
6. Mustanir, M.; Nurdin, N.; Ginting, B., Antioxidant Activity and Phytochemical Identification of Annona Squamosa Leaves Methanolic Extracts. Pharmacognosy Journal 2021, 13 (6s), 1746-1750.
7. Harahap, D.; Niaci, S.; Mardina, V.; Zaura, B.; Qanita, I.; Purnama, A.; Puspita, K.; Rizki, D. R.; Iqhrammullah, M., Antibacterial activities of seven ethnomedicinal plants from family Annonaceae. Journal of Advanced Pharmaceutical Technology & Research 2022, 13 (3), 148.
8. Ginting, B.; Saidi, N.; Murniana; Mustanir; Maulidna; Simanjuntak, P., Lignan compound isolated from n-Hexane extract Myristica fragrans Houtt root as antioxidant and antitumor activities against MCF-7 cell lines data. Data Brief 2020, 31, 105997.
9. Ginting, B.; Mustanir, M.; Nurdin, N.; Maulidna, M.; Murniana, M.; Safrina, S., Evaluation of antioxidant and anticancer activity of Myristica fragrans Houtt. bark. Pharmacognosy Journal 2021, 13 (3), 780-786.
10. Purnama, A.; Mustanir, M.; Ginting, B., Isolation and cytotoxic activity of terpenoid compounds from n-hexane extract of cacao pod husk (Theobroma cacao L.). AIP Conference Proceedings 2021, 2342, 030007.
11. Ginting, B.; Maulana, I.; Saidi, N.; Astryna, S. Y., Isolation and activity antioxidant test of cocoa pod husk ethyl asetat extracts (Theobroma cacao L). Jurnal Natural 2019, 19 (2), 49-53.
12. Mustanir; Nurdin; Ginting, B.; Purnama, A., Chemical composition and cytotoxic activities of n-Hexane extract from cacao pod husk (Theobroma cacao L.). Chemical Data Collections 2020, 30, 100553.
13. Ginting, B.; Maulana, I.; Karnila, I., Biosynthesis copper nanoparticles using Blumea balsamifera leaf extracts: Characterization of its antioxidant and cytotoxicity activities. Surfaces and Interfaces 2020, 21, 100799.
14. M, R.; Su, R.; Pandian A, M. K.; B, G.; Singh M, V. P., Green synthesis of titanium dioxide and its application on anti-fungal activity. Research Journal of Pharmacy and Technology 2022, 15 (2), 695-700.
15. Wang, Y. H.; Zhang, Y. R., Variations in compositions and antioxidant activities of essential oils from leaves of Luodian Blumea balsamifera from different harvest times in China. PLoS One 2020, 15 (6), e0234661.
16. Ma, J.; Ren, Q.; Dong, B.; Shi, Z.; Zhang, J.; Jin, D. Q.; Xu, J.; Ohizumi, Y.; Lee, D.; Guo, Y., NO inhibitory constituents as potential anti-neuroinflammatory agents for AD from Blumea balsamifera. Bioorg Chem 2018, 76, 449-457.
17. Liao, J.; Xie, X.; Wang, W.; Gao, Y.; Cai, Y.; Peng, J.; Li, T.; Yi, Q.; He, C.; Wang, L., Anti-inflammatory Activity of Essential Oil from Leaves of Blumea balsamifera (L.) DC through Inhibiting TLR4/NF-kB Signaling Pathways and NLRP3 Inflammasome Activation in LPS-induced RAW264.7 Macrophage Cells. Journal of Essential Oil Bearing Plants 2021, 24 (2), 160-176.
18. Han, L.; Song, H.; Fu, L.; Li, J.; Yang, L.; Liu, H., Effect of extraction method on the chemical profiles and bioactivities of soybean hull polysaccharides. Food Sci Nutr 2021, 9 (11), 5928-5938.
19. Bharathi, P. M.; V, A.; Prasad, S. S.; Vali, S. C.; P. Krishna, V. M., Phytochemical screening and antipyretic activity of Atylosia rugosa. Research Journal of Pharmacy and Technology 2022, 15 (2), 701-706.
20. Sumitha, A.: Dhanasekaran, R.: Archana, A: Sridevi, S. A.: Thamizharasan, S.: Brethis, C. S.,, Phyllanthus seeds Methanolic extract: In vivo evaluation of Analgesic activity. Research Journal of Pharmacy and Technology 2022, 15 (2), 713-716.
21. Sahu, D.; Bolleddu, R.; Das, M.; Das, D.; Mandal, T. K.; Debnath, S. K.; Barik, L.; Dahiya, J.; Mandal, S.; Prasad, P. V. V., Pharmacognostical and phytochemical studies of leaves of Plectranthus amboinicus (Lour.) Spreng. (Parnayavani). Research Journal of Pharmacy and Technology 2022, 15 (2), 717-722.
22. Mr, M.; A, Z., Antioxidant activity of methanol extract/fractions of senggani leaves (Melastoma candidum D. Don). Pharmaceutica Analytica Acta 2017, 08 (08).
23. Kaur, G.; Gautam, S.; Arora, P.; Dhingra, N., Estimation of synergistic antioxidant effect of methanolic extracts of some medicinal herbs Research Journal of Pharmacy and Technology 2022, 15 (3), 1042-6.
24. Puspitarini, S.; Widodo, N.; Widyarti, S.; Jatmiko, Y. D.; Rifa’i, M., Polyherbal effect between Phyllanthus urinaria and Curcuma longa as an Anticancer and Antioxidant. Research Journal of Pharmacy and Technology 2022, 15 (2), 671-678.
25. Maulana, I.; Fasya, D.; Ginting, B., Biosynthesis of Cu nanoparticles using Polyalthia longifolia roots extracts for antibacterial, antioxidant and cytotoxicity applications. Materials Technology 2022, 1-5.
26. Hasballah, K.; Sarong, M.; Rusly, R.; Fitria, H.; Maida, D. R.; Iqhrammullah, M., Antiproliferative activity of triterpenoid and steroid compounds from ethyl acetate extract of Calotropis gigantea root bark against P388 murine leukemia cell lines. Scientia Pharmaceutica 2021, 89 (2), 21.
27. Anggi, V.; Masyita, A. A., Combination effects of Abelmoschus manihot (L.) Medik of n-hexane extracts and doxorubicin in breast cancer 4t1 cells line. Research Journal of Pharmacy and Technology 2022, 15 (2), 639-2.
28. Quranayati, Q.; Iqhrammullah, M.; Saidi, N.; Nurliana, N.; Idroes, R.; Nasution, R., Cytotoxicity and phytochemical profiles of Phyllanthus emblica stem barks with in silico drug-likeliness: Focusing on antidiabetic potentials. Journal of Advanced Pharmaceutical Technology & Research 2022, 13 (4), 281.
29. Norikura, T.; Kojima-Yuasa, A.; Shimizu, M.; Huang, X.; Xu, S.; Kametani, S.; Rho, S. N.; Kennedy, D. O.; Matsui-Yuasa, I., Anticancer activities and mechanisms of Blumea balsamifera extract in hepatocellular carcinoma cells. Am J Chin Med 2008, 36 (2), 411-424.
30. Gore, M.; Desai, N. S., Characterization of phytochemicals and evaluation of anti-cancer potential of Blumea eriantha DC. Physiol Mol Biol Plants 2014, 20 (4), 475-486.
31. Purnama, A.; Rizki, D. R.; Qanita, I.; Iqhrammullah, M.; Ahmad, K.; Mardina, V.; Puspita, K.; Hasballah, K., Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer. J. Adv. Pharm. Technol. Res. 2022, 13 (1), 44-49.
32. Purnama, A.; Mardina, V.; Puspita, K.; Qanita, I.; Rizki, D. R.; Hasballah, K.; Iqbal, M.; Sarong, M., Molecular docking of two cytotoxic compounds from Calotropis gigantea leaves against therapeutic molecular target of pancreatic cancer. Narra J 2021, 1 (2), e37.
33. Une, H. D.; Bhagure, L. B., The anti-leukemic potential of Cyclea peltata as validated by phytochemical and cell line studies. Research Journal of Pharmacy and Technology 2022, 15 (3), 1064-0.
34. Widhiantara, I. G.; Jawi, I. M., Phytochemical composition and health properties of Sembung plant (Blumea balsamifera): A review. Vet World 2021, 14 (5), 1185-1196.
35. Ragasa, C. Y.; Co, A. L.; Rideout, J. A., Antifungal metabolites from Blumea balsamifera. Nat Prod Res 2005, 19 (3), 231-237.
36. Ma, R.; Xie, Q.; Li, H.; Guo, X.; Wang, J.; Li, Y.; Ren, M.; Gong, D.; Gao, T., l-Borneol exerted the neuroprotective effect by promoting angiogenesis coupled with neurogenesis via Ang1-VEGF-BDNF pathway. Front Pharmacol 2021, 12, 641894.
37. Silva-Filho, J. C.; Oliveira, N. N.; Arcanjo, D. D.; Quintans-Junior, L. J.; Cavalcanti, S. C.; Santos, M. R.; Oliveira Rde, C.; Oliveira, A. P., Investigation of mechanisms involved in (-)-borneol-induced vasorelaxant response on rat thoracic aorta. Basic Clin Pharmacol Toxicol 2012, 110 (2), 171-177.
38. Su, J.; Lai, H.; Chen, J.; Li, L.; Wong, Y. S.; Chen, T.; Li, X., Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. PLoS One 2013, 8 (5), e63502.
39. Cao, W. Q.; Li, Y.; Hou, Y. J.; Yang, M. X.; Fu, X. Q.; Zhao, B. S.; Jiang, H. M.; Fu, X. Y., Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal. Biomed Pharmacother 2019, 118, 109261.
40. Mirzania, F.; Sarrafi, Y.; Farimani, M. M., Comparison of chemical composition, antifungal and antibacterial activities of two populations of Salvia macilenta Boiss. essential oil. Records of Natural Products 2018, 12 (4), 385-390.
41. Khalaf, O. M.; Abdel-Aziz, M. S.; El-Hagrassi, A. M.; Osman, A. F.; Ghareeb, M. A., Biochemical aspect, antimicrobial and antioxidant activities of melaleuca and syzygium species (myrtaceae) grown in Egypt. Journal of Physics: Conference Series 2021, 1879 (2), 022062.
42. Mouchira, A. C., Chemical composition and anticancer activity of Achillea fragrantissima (Forssk.) Sch. Bip. (Asteraceae) essential oil from Egypt. Journal of Pharmacognosy and Phytotherapy 2017, 9 (1), 1-5.
Received on 08.04.2022 Modified on 20.08.2022
Accepted on 12.11.2022 © RJPT All right reserved
Research J. Pharm. and Tech 2023; 16(4):1664-1668.
DOI: 10.52711/0974-360X.2023.00272